EMR
August 6, 2025 - AI Summary
Overvalued by 55.3% based on the discounted cash flow analysis.
Market cap | $74.29 Billion |
---|---|
Enterprise Value | $88.06 Billion |
Dividend Yield | $2.11 (1.60%) |
Earnings per Share | $3.44 |
Beta | 1.31 |
Outstanding Shares | 562,100,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 27.98 |
---|---|
PEG | 35.82 |
Price to Sales | 4.18 |
Price to Book Ratio | 3.7 |
Enterprise Value to Revenue | 4.95 |
Enterprise Value to EBIT | 34.2 |
Enterprise Value to Net Income | 33 |
Total Debt to Enterprise | 0.18 |
Debt to Equity | 0.8 |
No data
No data